All 156 subjects who received trial treatment were included in the analyses
Switching from semaglutide to tirzepatide dosing typically involves starting tirzepatide at the initial recommended dose (e.g., 2.5 mg) regardless of the prior semaglutide dose, to assess tolerance and minimize gastrointestinal side effects
Furthermore, SP can directly inhibit insulin-dependent glucose metabolism in rat adipocytes (81)
Severe Gastrointestinal Disease Individuals with high-risk GI conditions, like Crohns, ulcerative colitis, or bowel blockages, might not tolerate retatrutide
Contact the customer support team to get the assistance you need
If you're looking for a weight loss solution that works, talk to your healthcare provider about Semaglutide